mounjaro glp 1 gip Results were over 72 weeks. (Tirzapatide) is a GLP-1 + GIP, dual-acting drug. The (Glucagon Like Peptide)-1 component is mainly known for appetite control, but it also: • Improves insulin Understand Mounjaro Weight Loss by

Supplements include probiotics, melatonin, and flaxseed

Clinical scenarios warranting consideration of GLP-1 therapy include: Type 2 diabetes management : Per ADA 2024 Standards of Care, GLP-1 RAs may be considered as initial therapy in patients with established atherosclerotic cardiovascular disease (ASCVD), high ASCVD risk, chronic kidney disease (CKD), or heart failure, or as add-on therapy when glycemic targets aren't met Established cardiovascular disease : Several GLP-1 receptor agonists have demonstrated cardiovascular risk reduction in patients with type 2 diabetes and established ASCVD Chronic kidney disease : While SGLT2 inhibitors are generally prioritized for CKD with type 2 diabetes when eGFR allows, GLP-1 RAs may provide complementary benefits Obesity with complications : When lifestyle interventions produce insufficient weight loss in patients with obesity-related comorbidities Important safety considerations include: Contraindications : Personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2

Frontiers in Neuroscience , 7:181

Qu dice la evidencia: La L-arginina tiene una funcin fisiolgica real, pero sus efectos como suplemento dependen de la dosis, la persona, el objetivo, la forma usada y el contexto